- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Neoplasms, Plasma Cell
Medical specialists from France tagged as investigators in clinical trials studying Neoplasms, Plasma Cell
Total 102 results
-
ManierSeen in:
- Lille, CHRU Hopital Claude Huriez
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
Manuel CLIQUENNOIS, MDSeen in:
- Lille, Hopital St Vincent - Ghicl
Trials:- NCT02066454 (Principal Investigator)
Conditions: -
Marc WETTERWALD, MDSeen in:
- Dunkerque, Centre Hospitalier
Trials:- NCT02066454 (Principal Investigator)
Conditions: -
Maria Joao Santiago-Ribeiro, MDSeen in:
- Tours, CHU de Tours
Trials:- NCT03832127 (Principal Investigator)
Conditions: -
Marie-Lorraine ChretienSeen in:
- Dijon, CHU Dijon - Hopital du Bocage
Trials:- NCT05879757 (Principal Investigator)
Conditions: -
Mohamad MOHTYSeen in:
- Ile-de-france, Paris Cedex 12, Hopital Saint-Antoine
- Paris, Hopital Saint Antoine
Trials:- NCT03215030 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions: -
MohtySeen in:
- Paris, CHU Hopital Saint Antoine
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
moreauSeen in:
- Nantes, CHRU Hôtel Dieu
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
MorelSeen in:
- Paris, La Pitié
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
Mourad TIAB, MDSeen in:
- La Roche Sur Yon, CHD Vendée
- La Roche sur Yon, Hematology Unit CHD Vendée
Trials:- NCT01976182 (Principal Investigator)
- NCT02066454 (Principal Investigator)
Conditions: -
Nicolas Aide, MDSeen in:
- Caen, CHU de Caen
Trials:- NCT03832127 (Principal Investigator)
Conditions: -
Omar BenbrahimSeen in:
- Orleans, Hopital de la Source - CHR Orleans
Trials:- NCT05879757 (Principal Investigator)
Conditions: -
Pacôme Fosse, MDSeen in:
- Angers, CHU d'Angers
Trials:- NCT03832127 (Principal Investigator)
Conditions: -
Pascale CONY-MAKHOUL, MDSeen in:
- Annecy, CHRA
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
PerrotSeen in:
- Toulouse, Pôle IUCT Oncopole CHU
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
Philippe ReySeen in:
- Lyon cedex 08, GSK Investigational Site
- Lyon, Centre Leon Berard
Trials:- NCT04126200 (Principal Investigator)
- NCT04052126 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
- NCT05947136 (Sub-Investigator)
- NCT02066454 (Principal Investigator)
Conditions:- Multiple Myeloma;
- Quality of Life;
- Lymphoma, Non-Hodgkin;
- Leukemia, Myeloid, Acute;
- Fatigue;
- Exercise;
- Aged;
- Aged, 80 and Over;
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC;
- Complication;
- Venous Thromboembolism;
- Myeloma
-
Philippe RodonSeen in:
- Périgueux cedex, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Pierre BIRON, MDSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT01774409 (Sub-Investigator)
- NCT02066454 (Sub-Investigator)
Conditions: -
Pierre Bories, MDSeen in:
- Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole
Trials:- NCT05651932 (Principal Investigator)
Conditions: -
Pierre FAURISeen in:
- Chambéry, Centre Hospitalier Metropole Savoie - Investigational Site Number : 2500006
Trials:- NCT04458831 (Principal Investigator)
Conditions: -
Pierre Fenaux, MDSeen in:
- Paris, Hôpital St Louis
Trials:- NCT02649790 (Principal Investigator)
- NCT02473146 (Principal Investigator)
-
Pierre FeugierSeen in:
- Nancy, CHU Nancy
- Other, Vandoeuvre-Les-Nancy Cedex 9, Centre Hospitalier Universitaire de Nancy - Hôpital de Brabois
- Vandeouvre-les-Nancy, GSK Investigational Site
- Vandœuvre-lès-Nancy, CHU de Nancy - Hôpital de Brabois Adultes
- Vandœuvre-lès-Nancy, Chu De Nancy Hop D'Adultes De Brabois
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT05246345 (Principal Investigator)
-
Pierre Yvese Salaün, MDSeen in:
- Brest, CHU de Brest
Trials:- NCT03832127 (Principal Investigator)
Conditions: -
Rémy GRESSIN, MDSeen in:
- Grenoble, CHU Grenoble
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Reza TabriziSeen in:
- Mont-de-Marsan, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
Conditions: -
Salomon ManierSeen in:
- Hauts-de-France, Lille, CHRU Lille
- NORD Pas-de-calais, Lille Cedex, Centre Hospitalier Régional Universitaire de Lille
Trials:- NCT03215030 (Principal Investigator)
- NCT05590377 (Principal Investigator)
Conditions: -
Sophie GODETSeen in:
- Reims, CHU Reims - Hôpital Robert Debré - Investigational Site Number : 2500010
Trials:- NCT04458831 (Principal Investigator)
Conditions: -
Stéphane COURBY, MDSeen in:
- Grenoble, CHU Grenoble
Trials:- NCT02066454 (Sub-Investigator)
Conditions:
Clinical Trials on Neoplasms, Plasma Cell
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States